manilatimes46m
Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data ...
manilatimes46m
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
Mr. Pasternak brings decades of global pharmaceutical leadership experience ...
manilatimes46m
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2024 Update
Postal Realty Trust, Inc. (NYSE: PSTL) (the "Company”), an internally managed real estate investment trust that owns and ...
manilatimes46m
Traxys and HNK Alpha Execute First Nickel Sulphate Futures Block Trade on Abaxx Commodity Futures Exchange and Clearinghouse
"Traxys is proud to be at the origin of the first Nickel Sulphate trade on the newly created Abaxx international exchange,” said Jan Wessels, Head of Nickel, Traxys. "We are pleased with the launch of ...
manilatimes46m
Amalgamated Financial Corp. Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
Amalgamated Financial Corp. ("Amalgamated” or the "Company”) (Nasdaq: AMAL) today announced that its fourth quarter and full year 2024 financial results will be released before market open on Thursday ...